NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 30.8M shares, a 28.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 30.8M +6.89M +28.8% Sep 30, 2024 10-K 2024-12-17
Q2 2024 27.8M +9.98M +55.9% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 26.3M +9.43M +55.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 24.8M +8.59M +52.9% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 23.9M +7.71M +47.6% Sep 30, 2023 10-K 2024-12-17
Q2 2023 17.9M +1.67M +10.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 16.9M +697K +4.3% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 16.2M +50.7K +0.31% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 16.2M +4.21M +35% Sep 30, 2022 10-K 2023-12-15
Q2 2022 16.2M +4.21M +35.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 16.2M +4.28M +35.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 16.2M -6.9M -29.9% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 12M +4.62M +62.4% Sep 30, 2021 10-K 2022-12-22
Q2 2021 12M -6.26M -34.3% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 11.9M -2.11M -15.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 23.1M +9.35M +68.1% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 7.39M -6.1M -45.2% Sep 30, 2020 10-K/A 2022-05-31
Q2 2020 18.2M +4.82M +35.9% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 14M +1.08M +8.33% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 13.7M +3.7M +36.9% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 13.5M +3.84M +39.7% Sep 30, 2019 10-K 2020-12-09
Q2 2019 13.4M +5.4M +67.4% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 12.9M +5.08M +64.6% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 10M +2.17M +27.6% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 9.66M +1.79M +22.8% Sep 30, 2018 10-K 2019-12-20
Q2 2018 8.01M +2.94M +58% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 7.86M +2.79M +55% Mar 31, 2018 10-Q 2018-05-16
Q4 2017 7.86M +2.65M +50.8% Dec 31, 2017 10-KT/A 2019-03-18
Q3 2017 7.86M +2.79M +55% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 5.07M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 5.07M 0 0% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 5.22M +144K +2.83% Dec 31, 2016 10-K 2018-04-16
Q3 2016 5.07M 0 0% Sep 30, 2016 10-Q 2016-11-21
Q2 2016 5.07M 0 0% Jun 30, 2016 10-Q 2016-08-19
Q1 2016 5.07M 0 0% Mar 31, 2016 10-Q 2016-05-23
Q4 2015 5.07M 0 0% Dec 31, 2015 10-K 2017-04-17
Q3 2015 5.07M 0 0% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 5.07M 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 5.07M 0 0% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 5.07M 0 0% Dec 31, 2014 10-K 2016-04-14
Q3 2014 5.07M Sep 30, 2014 10-Q 2014-11-19
Q2 2014 5.07M Jun 30, 2014 10-Q 2014-08-18
Q1 2014 5.07M 0 0% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 5.07M 0 0% Dec 31, 2013 10-K 2015-04-15
Q1 2013 5.07M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 5.07M +573K +12.7% Dec 31, 2012 10-K/A 2014-04-24
Q3 2012 5.07M Sep 30, 2012 10-Q 2012-11-13
Q4 2011 4.5M 0 0% Dec 31, 2011 10-Q 2012-11-13
Q4 2010 4.5M Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.